Showing results (651-660 of 1,163) with videos related to
Sort By:
Pageof 117
Clinical Cardiology|June 21, 2020
Ethnic differences in quality of life and its association with survival in patients with heart failureGillian Stein, Tiew-Hwa K Teng, Wan T Tay, et al.Diabetes, Obesity & Metabolism|July 8, 2022
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidenceKamlesh Khunti, Vanita R Aroda, Deepak L Bhatt, et al.European Journal of Heart Failure|October 7, 2017
Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurementsYoran M Hummel, Licette C Y Liu, Carolyn S P Lam, et al.Frontiers in Immunology|April 4, 2022
Pro-Inflammatory Derangement of the Immuno-Interactome in Heart FailurePavanish Kumar, Amanda Lim, Su Li Poh, et al.Plos Medicine|March 28, 2018
Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registryJasper Tromp, Wan Ting Tay, Wouter Ouwerkerk, et al.The Lancet Regional Health. Western Pacific|February 1, 2024
Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong KongQing-Wen Ren, Tiew-Hwa Katherine Teng, Yi-Kei Tse, et al.Journal of the American Heart Association|August 22, 2019
Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection FractionJonathan Yap, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.Journal of Cardiac Failure|May 23, 2023
Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF TrialJohn W Ostrominski, Brian L Claggett, Milton Packer, et al.Cardiovascular Diabetology|February 2, 2024
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trialJames L Januzzi, Stefano Del Prato, Julio Rosenstock, et al.Nature Medicine|March 30, 2026
The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trialScott D Solomon, John J V McMurray, G Michael Felker, et al.Pageof 117